Dale E. Bredesen, M.D.
Dr. Bredesen received his undergraduate degree from Caltech and his medical degree from Duke. He served as Resident and Chief Resident in Neurology at UCSF, then was postdoctoral fellow in the laboratory of Nobel laureate Prof. Stanley Prusiner. He was a faculty member at UCLA from 1989-1994, then was recruited by the Burnham Institute to direct the Program on Aging. In 1998 he became the Founding President and CEO of the Buck Institute for Research on Aging, and Adjunct Professor at UCSF; then in 2013 he returned to UCLA as the Director of the Easton Center for Alzheimer’s Disease Research.
The Bredesen Laboratory studies basic mechanisms underlying the neurodegenerative process, and the translation of this knowledge into effective therapeutics for Alzheimer’s disease and other neurodegenerative conditions, leading to the publication of over 220 research papers. He established the ADDN (Alzheimer’s Drug Development Network) with Dr. Varghese John in 2008, leading to the identification of new classes of therapeutics for Alzheimer’s disease. He and his group developed a new approach to the treatment of Alzheimer’s disease, and this approach led to the discovery of subtypes of Alzheimer’s disease, followed by the first description of reversal of symptoms in patients with MCI and Alzheimer’s disease, with the ReCODE (reversal of cognitive decline) protocol, published in 2014, 2016, and 2018. His book, The End of Alzheimer’s, is a New York Times Bestseller.
Christopher Shade, PhD
Dr. Shade specializes in the biological, environmental, and analytical chemistry of mercury in all its forms and their interactions with sulfur compounds, particularly glutathione and its enzyme system. He has patented analytical systems for mercury speciation (separation of different forms of mercury), founded the only clinical lab in the world offering mercury speciation in human samples, and has designed cutting edge systems of nutraceuticals for detoxification and antioxidant protection, including novel phospholipid delivery systems for both water- and fat-soluble compounds.
Dr Shade received his PhD in 2005 in Environmental Science/Aquatic Chemistry, from University of Illinois at Urbana-Champaign.
Todd A. Born, ND, CNS
Title: A Comprehensive, Integrative Approach to Dementia
Dr. Born is a naturopathic physician, certified nutrition specialist (CNS), co-owner and medical director of Born Integrative Medicine Specialists, PLLC. Dr. Born is the Product Manager, Head of New Product Development, Scientific Advisor for Allergy Research Group and is Editor-in-Chief of their science-based Focus Newsletter. Dr. Born is also lead advisor and President of the International Society for Naturopathic Medicine, as well as a medical wellness advisor for the International Medical Wellness Association.
Dr. Born graduated from Bastyr University in Seattle, WA in 2010 and completed his residency at the Bastyr Center for Natural Health, its thirteen teaching clinics, with rotations at Evergreen and Harborview Medical Centers’ Emergency Medicine Departments, and Virginia Mason Hospital’s department of Physical Medicine and Rehabilitation Spine Clinic.
He is extensively published, has appeared on KRON4 News, multiple national radio shows, and lectured as an expert for the National Psoriasis Foundation and National Arthritis Foundation. Dr. Born lectures at medical conferences across the country and internationally.
Dr. Born’s clinical focus is utilizing integrative medicine to treat families of all ages with complex chronic diseases, with a strong interest in difficult and refractory cases, cardiovascular disease, diabetes, autoimmune disease, allergies, endocrine, neurological and GI issues.
Neil Nathan, MD
Title: Mold Toxicity and Its Effects on Cognition and Vitality
Neil Nathan, MD has been practicing medicine for 46 years, and has been Board Certified in Family Practice and Pain Management and is a Founding Diplomate of the American Board of Integrative Holistic Medicine. With Dr. Rich van Konynenburg he did the ground-breaking clinical research which demonstrated the importance of methylation chemistry in Chronic Fatigue Syndrome. He has written several books, including Healing is Possible: New Hope for Chronic Fatigue, Fibromyalgia, Persistent Pain, and Other Chronic Illnesses and On Hope and Healing: For Those Who Have Fallen Through the Medical Cracks. He has hosted an internationally syndicated radio program/podcast on Voice America called The Cutting Edge of Health and Wellness Today. He has been working to bring an awareness that mold toxicity is a major contributing factor for patients with chronic illness and lectures internationally on this subject which led to the publication of his book, Mold, and Mycotoxins: Current Evaluation and Treatment, followed in 2018 with his book Toxic: Heal Your Body from Mold Toxicity, Lyme Disease, Multiple Chemical Sensitivities, and Chronic Environmental Illness.
Dr. Nathan has been treating chronic complex medical illnesses for over 25 years and Lyme disease for the past 15 years. As his practice has evolved, he finds himself increasingly treating the patients who have become so sensitive and toxic that they can no longer tolerate their usual treatments, and his major current interest is in finding unique ways of helping them to recover. The recent findings that mast cell activation and porphyria are more common than has been appreciated by the medical profession are of particular importance in this regard.
His current medical practice is the Redwood Valley Clinic in Northern California.
Sonia Rapaport, MD
Title: Infections and the Immune System and Their Roles in Cognition and Vitality
Sonia Rapaport, MD, DABFM, DABIHM, DNBPAS, is a conventionally trained family doctor and integrative physician. She graduated from the University of Virginia, where she received honors for her clinical work, and upon completion of a Family Medicine Residency at the University of Pittsburgh Medical Center, was board certified in Family Medicine. She is a Diplomate of the National Board of Physicians and Surgeons (NBPAS), the American Board of Integrative and Holistic Medicine (ABIHM), and is a co-Founder and the Founding President of ISEAI.
In 2007 she founded Haven Medical, which has evolved into a multi-practitioner integrative center focusing on the diagnosis and treatment of complex medical conditions such as environmentally acquired illnesses. She began treating biotoxin illness in 2010 and was certified to treat CIRS in 2014. She continues to build on that foundation with a systems biology approach incorporating functional and integrative medicine, an approach that she has found to be the most effective in helping people work towards their optimal health.
Dr. Rapaport works collaboratively with patients, personalizing recommendations for each individual’s unique story. Her research and clinical interests include the effects of ongoing stress on the autonomic nervous system and mitochondrial health, and she was a leading physician in the recognition of mitochondrial dysfunction in EAI. She has explored how environmental exposures and infections such as Lyme disease and other tick-borne illnesses impact the immune system, and is also interested in how mast cells are activated and why this is more commonly seen in dysautonomias and hypermobility. She sees a broad range of patients, including those suffering from fatigue, POTS and dysautonomias, MCS, and cognitive impairment. She is a Bredesen certified physician.
Her advocacy work has included serving on the Board of Directors of the American Holistic Medical Association, founding and serving as President of Familial Dysautonomia Hope Foundation, and speaking at the NIH conference on inherited dysautonomias. She has lectured nationally and internationally on environmentally acquired illness, integrative medicine, and narrative medicine. Dr. Rapaport holds an MA in medical anthropology, an MFA in creative writing, and is a WTA certified Tea Sommelier, and Tea and Health Expert.